CTSA INFRASTRUCTURE FOR AIDS RESEARCH

CTSA 艾滋病研究基础设施

• 批准号: 8365047
• 负责人: ERIC S. ORWOLL
• 金额: $ 7.94万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8365047
• 关键词: Acquired Immunodeficiency Syndrome; Clinical Research; Oregon; Research; Research Infrastructure; Research Institute; Translational Research

This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. DESCRIPTION (provided by applicant): After a successful and highly productive first grant period, the Oregon Clinical and Translational Research Institute (OCTRI) is well positioned to have greater impact in the next grant period. OCTRI's goals are: Specific Aim 1. Generate sustained OHSU and KPCHR research growth and productivity across the spectrum of translational science. Specific Aim 2. Translate new biomedical knowledge into widespread advances in human health and healthcare reform. Specific Aim 3. Create a regional consortium for clinical and translational research. Specific Aim 4. Expand the impact of the strong OCTRI educational curriculum, develop an institution-wide, coordinated career development process that builds on the strengths of existing programs, and extend it throughout the region and nationally. Specific Aim 5. Enhance key infrastructure programs to support local and regional clinical and translational research. These plans will build on major progress during the first grant period to further expand clinical and translational research, career development and benefits to human health. OCTRI will utilize a series of innovative partnerships to leverage CTSA support, expand its extensive collaborations with communities, and take advantage of a regional consortium of academic institutions working together to enhance translation. As a member of the CTSA Consortium, OCTRI will contribute unique expertise and resources to the combined effort to solve biomedical problems. Oregon Health and Science University and its partner institution Kaiser Permanente Center for Health Research have committed strong leadership support and substantial institutional commitment to OCTRI's continued mission. PUBLIC HEALTH RELEVANCE (provided by applicant): OCTRI will have a major influence on clinical and translational research at OHSU and KPCHR, and will increase their contributions to biomedical discovery. As the only academic medical center in Oregon, OHSU has a unique opportunity to catalyze translational research growth on a regional scale. Via its participation in the CTSA Consortium, OCTRI will advance national research productivity.

该子项目代表了 CTSA 资金百分比的估计 被用于广泛的研究领域（艾滋病研究、儿科研究或 临床试验）。 列出的总成本只是 CTSA 金额的估计值 该研究领域的基础设施，而不是直接资助 NCRR 向子项目或子项目人员提供的补助金。 描述（由申请人提供）：在成功且富有成效的第一个资助期之后，俄勒冈州临床和转化研究所 (OCTRI) 已做好准备，在下一个资助期产生更大的影响。 OCTRI 的目标是： 具体目标 1. 在转化科学领域实现持续的 OHSU 和 KPCHR 研究增长和生产力。具体目标 2. 将新的生物医学知识转化为人类健康和医疗改革的广泛进步。具体目标 3. 创建临床和转化研究区域联盟。具体目标 4. 扩大 OCTRI 教育课程的影响力，在现有项目的优势基础上制定全机构范围内协调的职业发展流程，并将其扩展到整个地区和全国。具体目标 5. 加强关键基础设施计划，以支持地方和区域临床和转化研究。这些计划将建立在第一个拨款期间取得的重大进展的基础上，进一步扩大临床和转化研究、职业发展和对人类健康的益处。 OCTRI 将利用一系列创新合作伙伴关系来利用 CTSA 的支持，扩大与社区的广泛合作，并利用区域学术机构联盟的共同努力来加强翻译。作为 CTSA 联盟的成员，OCTRI 将贡献独特的专业知识和资源，共同努力解决生物医学问题。俄勒冈健康与科学大学及其合作机构凯撒永久健康研究中心为 OCTRI 的持续使命提供了强有力的领导支持和实质性的机构承诺。 公共卫生相关性（由申请人提供）：OCTRI 将对 OHSU 和 KPCHR 的临床和转化研究产生重大影响，并将增加他们对生物医学发现的贡献。作为俄勒冈州唯一的学术医疗中心，OHSU 拥有独特的机会来促进区域范围内转化研究的发展。通过参与 CTSA 联盟，OCTRI 将提高国家研究生产力。